The activation of an extracellular-signal regulated kinase by estradiolinterferes with the effects of trastuzumab on HER2 signalling in endometrialadenocarcinoma cell lines. - Treeck,O.; Diedrich,K.; Ortmann,O. (Eur J Cancer, 2003)